Kistler Tiffany Companies, LLC Crispr Therapeutics Ag Transaction History
Kistler Tiffany Companies, LLC
- $615 Million
- Q2 2023
A detailed history of Kistler Tiffany Companies, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 8,110 shares of CRSP stock, worth $403,229. This represents 0.07% of its overall portfolio holdings.
Number of Shares
8,110
Previous 7,267
11.6%
Holding current value
$403,229
Previous $328,000
38.72%
% of portfolio
0.07%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
494Shares Held
64.3MCall Options Held
1.68MPut Options Held
1.95M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$446 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$435 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$190 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$138 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$137 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.88B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....